Last reviewed · How we verify
intravenous lipid — Competitive Intelligence Brief
phase 3
Parenteral nutrition
Nutritional Support
Small molecule
Live · refreshed every 30 min
Target snapshot
intravenous lipid (intravenous lipid) — University of Rochester. Intravenous lipid emulsions provide a source of calories and essential fatty acids.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| intravenous lipid TARGET | intravenous lipid | University of Rochester | phase 3 | Parenteral nutrition | ||
| Lipofundin MCT | Lipofundin MCT | B. Braun Melsungen AG | marketed | Lipid emulsion for parenteral nutrition | ||
| lipid emulsion for TPN | lipid emulsion for TPN | National Taiwan University Hospital | marketed | Nutritional supplement / Parenteral nutrition component | ||
| Fat emulsion with MCT and LCT | Fat emulsion with MCT and LCT | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | marketed | Parenteral nutrition emulsion | ||
| ClinOleic (baseline) | ClinOleic (baseline) | General University Hospital, Prague | marketed | Lipid emulsion for parenteral nutrition | ||
| SMOFlipid (baseline) | SMOFlipid (baseline) | General University Hospital, Prague | marketed | Lipid emulsion for parenteral nutrition | ||
| Amino acid solution | Amino acid solution | B.P. Koirala Institute of Health Sciences | marketed | Parenteral nutrition supplement |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Parenteral nutrition class)
- University of Rochester · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- intravenous lipid CI watch — RSS
- intravenous lipid CI watch — Atom
- intravenous lipid CI watch — JSON
- intravenous lipid alone — RSS
- Whole Parenteral nutrition class — RSS
Cite this brief
Drug Landscape (2026). intravenous lipid — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-lipid. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing